The etiology for olfactory loss can in many cases be difficult to determine, but it is important to establish prognosis and to predict response to therapy. Diagnosis requires a thorough history, appropriate chemosensory testing, and a physical examination that should include nasal endoscopy. A trial of systemic steroids may serve to verify that the loss is indeed conductive.

The acquisition, maintenance, and extinction of autoshaped responding in pigeons were studied under partial and continuous reinforcement. Five values of probability of reinforcement, ranging from .1 to 1.0, were combined factorially with five values of intertrial interval ranging from 15 to 250 sec for different groups. The number of trials required before autoshaped responding emerged varied inversely with the duration of the intertrial interval and probability of reinforcment, but partial reinforcement did not increase the number of reinforcers before acquisition. During maintained training, partial reinforcement increased the overall rate of responding. A temporal gradient of accelerated responding over the trial duration emerged during maintenance training for partial reinforcement groups, and was evident for all groups in extinction. Partial reinforcement groups responded more than continuous reinforcement groups over an equivalent number of trials in extinction. However, this partialreinforcment extinction effect disappeared when examined in terms of the omission of "expected" reinforcers.

No abstract

No abstract

Hemodialysis vascular access dysfunction is a major cause of morbidity and hospitalization in the hemodialysis population at a cost of over USD 1 billion per annum. Most hemodialysis grafts fail due to a venous stenosis (venous neointimal hyperplasia) which then results in thrombosis of the graft. Despite the magnitude of the clinical problem there are currently no effective therapies for this condition. The current review (a) describes the pathogenesis and pathology of venous stenosis in dialysis access grafts and (b) discusses the development and application of novel therapeutic interventions for this difficult clinical problem. Special emphasis is laid on the fact that PTFE dialysis access grafts could be the ideal clinical model for testing out novel local therapies to block neointimal hyperplasia.